Covid-19 News: border closing between the United States and Canada extended for a month

The Covid-19-pandemic keeps the world in breath. More than 8.4 million people have been infected so far worldwide, with the novel Coronavirus, 187.942 in Germany – where it always comes back to local outbreaks. All the News on the Corona-crisis in Germany, Europe and the world read in the News-Ticker of FOCUS Online.

Covid-19-News from Germany and around the world – the top stories: industry: holiday homes in North sea and Baltic sea to 90 percent of capacity (08.13 am) study shakes now on, immunity-Thesis (06.47 PM) number of Corona new infections is rising again to more than 600, although not all of Tönnies-the cases recorded are (20.51 PM)

• Live card to the Virus outbreak and Coronavirus-Radar-facts and Figures
• More News, services, and ideas to the Corona pandemic, see our overview of the portal

Results of the tübingen-based vaccine trial are expected in the summer

08.14 PM: the head of The first clinical study with the Corona vaccine the company Curevac to the University hospital of Tübingen is expecting in two months, with the first results. "This is quite a fix gehen", Professor Peter Kremsner, Director of the Institute for tropical medicine, the drug is tested on said. The subjects of the investigations were underway on Thursday, but the first vaccination had not yet been made.

The first subject was a young man. "He will then überwacht&quot first 24 hours with us in the Department;, Kremsner said. The goal of the first Phase of the study was to learn about the compatibility and the immune system. After more than 100 healthy Volunteers between the ages of 18 and 60 years of age to participate in the study. dpa/Sebastian Gollnow/dpa/picture Icon , A man pipetted in a laboratory of the company CureVac, a blue liquid.

The tübingen-based company Curevac is working on so-called mRNA-vaccines. mRNA is a type of messenger molecule, in which the Instructions for the production of proteins is. For your vaccine Curevac have provided researchers mRNA with the Instruction for a Protein of the Coronavirus Sars-CoV-2. The human cells after vaccination of this Protein, which the body recognizes as foreign. He, however, makes antibodies and other immune cells.

For the University hospital of Tübingen, it was a home game, said Kremsner. In Phase two of the study, the group of subjects is to be extended to older people. Also, children should get the vaccine candidates at some point. Two months in the preparation of the study took approximately 30 employees were involved.

FOCUS Online/Wochit Merkel has AfD in the Bundestag with one-liners emergence and garners loud applause